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Abstract: Whilst there is a large body of evidence looking at the design of cationic 
liposomes as transfection agents, correlates of formulation to function remain elusive. In 
this research, we investigate if lipid packaging can give further insights into transfection 
efficacy. DNA lipoplexes composed of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
(DOPE) or 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE) in combination 
with 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) or 1,2-stearoyl-3-
trimethylammonium-propane (DSTAP) were prepared by the lipid hydration method. Each 
of the formulations was prepared by hydration in dH2O or phosphate buffer saline (PBS) to 
investigate the effect of buffer salts on lipoplex physicochemical characteristics and 
in vitro transfection. In addition, Langmuir monolayer studies were performed to 
investigate any possible correlation between lipid packaging and liposome attributes. Using 
PBS, rather than dH2O, to prepare the lipoplexes increased the size of vesicles in most of 
formulations and resulted in variation in transfection efficacies. However, one combination 
of lipids (DSPE:DOTAP) could not form liposomes in PBS, whilst the DSPE:DSTAP 
combination could not form liposomes in either aqueous media. Monolayer studies 
demonstrated saturated lipid combinations offered dramatically closer molecular packing 
compared to the other combinations which could suggest why this lipid combination could 
not form vesicles. Of the lipoplexes prepared, those formulated with DSTAP showed 
higher transfection efficacy, however, the effect of buffer on transfection efficiency was 
formulation dependent.  
OPEN ACCESS 
Pharmaceutics 2011, 3            
 
 
849 
Keywords: Langmuir studies; lipid packaging; cationic liposomes; gene delivery; 
transfection; electrolytes 
 
1. Introduction  
In the development of new healthcare strategies, correction of underlying pharmacology of diseases 
instead of alteration of symptoms remains a key goal. Gene therapy has been developed with this aim 
in hand and both genetic diseases and acquired diseases are two main groups of diseases which gene 
therapy could play an important role in their treatment [1]. Yet developments in gene therapy remain 
slow and the major unresolved concern with gene therapy is how to effectively deliver the gene to the 
target site. Although it has been known for some time that direct injection of naked DNA allows 
transgene expression in muscle [2], in most of the cases naked DNA molecules are not able to enter 
cells efficiently due to their large size, negative charge and nuclease mediated degradation in vivo [3]. 
Therefore, a delivery vehicle (vector) must be used to carry the gene into the target cell or tissue to 
save the gene from the above dangers.  
An ideal vector should be stable and have high efficiency, with minimal toxicity and unrestricted 
size limitation for genetic payload (which can include DNA, siRNA etc.). It should also be easy to 
prepare and be cost effective [4]. Amongst the two classic groups of vectors, viral vectors provide high 
transfection efficiency but these systems are still limited by the dogma of toxicity and immunogenic 
reactions and therefore much research has focused on the use of non-viral vectors, given their superior 
safety profile despite their lower efficacy. In the case of non-viral systems cationic liposomes, due to 
their ability to address several of the above criteria, has been widely investigated [510] and the 
electrostatic interaction between positive charge of cationic liposomes and negative charge of DNA 
make a complex of cationic liposome-DNA generally referred to as lipoplexes [11]. 
To develop lipoplexes with high transfection and low toxicity, several parameters should be taken 
into account such as: size, lipid/DNA charge ratio, net positive charge of the lipoplex, chemical 
structure of cationic lipid and helper lipid, and finally the structure of the complex itself [12]. However 
given the dynamic nature of these structures many factors, in addition to those already listed, can 
contribute to the resultant physico-chemical attributes of the lipoplex including the rate of mixing of 
the various components, the temperatures used and even the presence of electrolytes in the buffers 
used [1214]. Indeed recent research has shown that the presence of electrolyte within the aqueous 
media can influence both the physico-chemical properties and the in vivo efficacy of lipoplexes, with 
the authors demonstrating that the addition of low concentrations of sodium chloride to cationic 
liposomes during complex formation lead to an improved vaccine adjuvant action [15,16].  
Thus the aim of this research was to investigate the molecular interactions of lipids and the resultant 
lipoplexes properties and to attempt to correlate these with the transfection attributes of the system in a 
controlled in vitro environment. Therefore lipid monolayers were studied by Langmuir-Blodgett 
trough as such monolayers can be considered as building blocks for bilayer vesicles, consequently, 
studying these monolayers in an aqueous media (dH2O or PBS) at air/water interface, in combination 
with the lipid attributes may give insights into bilayer lipid packaging configuration and liposome 
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stability which could influence transfection [17]. Cationic liposomes were prepared in dH2O or the 
commonly used phosphate buffered saline (PBS) and the liposome physico-chemical characteristics 
considered such that the effect of electrolytes could be considered and correlated with the Langmuir 
studies. Of the cationic liposome systems tested, the combination of the fusogenic lipid DOPE with the 
cationic lipid DOTAP, is a frequently used composition due to its high in vitro transfection efficiency 
and optimal immune response [11,1822]. Therefore this was chosen for further investigation. To 
consider the effect of lipid acyl chains on their molecular packaging and lipoplex characteristics were 
also systematically compared using DOPE and DOTAP with their disteroyl equivalents (DSPE and 
DSTAP) (Figure 1). 
Figure 1. Molecular structure of DOPE and DSPE and the cationic lipids DOTAP and 
DSTAP used. (DOPE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DSPE:  
1,2-distearoyl-sn-glycero-3-phosphoethanolamine, DOTAP: 1,2-dioleoyl-3-
trimethylammonium-propane, DSTAP: 1,2-stearoyl-3-trimethylammonium-propane). 
 
2. Materials and Methods 
2.1. Materials 
1,2-Dioleoyl-sn-glycero-3-phsphoethanolamine (DOPE), 1,2-dioleoyl-3-trimethylammonium-
propane (DOTAP), 1,2-stearoyl-3-trimethylammonium-propane (DSTAP) and 1,2-distearoyl-sn-
glycero-3-phosphoethanolamine (DSPE) were purchased from Avanti Polar Lipids, Inc. (Alabaster, 
AL). Ethylenediaminetetraacetic acid (EDTA) and phosphate buffer saline (PBS) tablets were 
purchased from Sigma-Aldrich Company (Poole, UK). Ethanol, methanol and chloroform (all HPLC 
grade) were purchased from Fisher Scientific (Leicestershire, UK). PicoGreen
®
 and Lipofectin
TM
 
reagents were obtained from Invitrogen Life Technologies and the luciferase assay kit and CellTiter 
96
®
 AQueous One Solution Cell Proliferation Assay were both obtained from Promega (Madison, WI). 
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Serum free and antibiotic free medium (opti-MEM), Dulbeccos modified Eagles medium (DMEM), 
L-glutamine/Penicillin-Streptomycin and foetal bovine serum (FBS) were purchased from  
Gibco-Invitrogen Ltd. (Paisley, UK). gWiz
TM
 Luciferase was obtained from Genovac GmbH, 
Germany. The African green monkey kidney cells (COS-7 cells) were purchased from European 
collection of cell cultures (ECACC) a Health Protection Agency Culture Collection (Salisbury, UK).  
2.2. Liposome Preparation 
All cationic liposomes were prepared by the lipid hydration method based on the work of Bangham 
et al., in 1965 [23]. Briefly the required lipid mixture of a helper lipid and a cationic lipid, at (8:8) PM 
ratio were dissolved in chloroform:methanol (9/1 v/v) in a round bottom flask and a dry lipid film 
produced by rotary evaporation at 37 °C. Any residual solvent was removed from the final dry lipid 
film by a stream of oxygen-free nitrogen. The dried lipid films were suspended in distilled water or 
PBS as appropriate and vortexed vigorously until all of the lipid film came into suspension to produce 
multilamellar vesicles (MLV), which were subject to sonication (1 minute at 5 amplitude microns) to 
produce small unilamellar vesicles (SUV).  
2.3. Preparation of Cationic Liposome/DNA Complexes (Lipoplexes) 
Cationic liposome-DNA complexes were prepared by adding different ranges of plasmid DNA 
content (2.5, 25, 50, 100, 200 and 1600 Pg) and incubated at room temperature for 30 minutes. To 
perform in vitro studies, lipoplexes was prepared by diluting 17.5 ȝ/ SUV solution to 0.35 mL with 
opti-MEM, which was then incubated for 40 minutes at room temperature. After incubation, 0.35 mL 
of opti-MEM containing 3.5 Pg plasmid DNA was added, and gently mixed with SUV solution and 
incubated again for a further 15 min at room temperature. The resultant SUV-DNA mixture was then 
diluted to a final volume of 3.5 mL with opti-MEM.  
2.4. Determination of Lipoplex Size and Zeta Potential 
The z-average diameter of lipoplexes was determined by dynamic light scattering using the photon 
correlation spectroscopy (PCS) technique measured on a Malvern Zetasizer Nano-ZS (Malvern 
Instruments Ltd., UK). The zeta potential (an indirect measurement of the vesicle surface charge) of 
the complexes was measured on Malvern Zetasizer NAni-ZS (Malvern Instruments Ltd., UK) at 25 °C 
in distilled water or PBS as appropriate.  
2.5. DNA Association Within Lipoplexes 
To measure the association of the DNA with liposomes, the preparation was centrifuged (Optima
TM
 
Max-xp Ultra Centrifuge; Beckman Coulter, USA) for one hour with the speed of 125,000 × g at 4 °C. 
After centrifugation, the supernatant were collected and the pellets were resuspended in appropriate 
media and centrifuge repeated for second time. By adding 100 ȝ/ PicoGreen® as a fluorescent dye to 
the 100 ȝ/ of supernatants in a 96 well plate and incubation of them up to 5 minutes at room 
temperature, the absorbance was read by SpectroMax Gemini EM (Molecular Device) plate reader, the 
amount of non-incorporated DNA was measured.  
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2.6. In Vitro Transfection of COS-7 Cells 
African green monkey kidney cells (COS-7 cells) were maintained at 37 °C under 5% CO2 in 
Delbeccos modified Eagles medium (DMEM) with 4 mM L-glutamine and supplemented with 10% 
(v/v) foetal bovine serum (FBS), penicillin (100 U/mL) and streptomycin (100 Pg/mL). COS-7 cells 
were plated 24 hours prior to transfection, at a cell concentration of 1 × 10
5
 cells/mL in 1 mL of 
medium in a 12-well plate and incubated overnight. Prior to transfection, cells were washed with 1 mL 
of opti-MEM before lipoplexes were added to the cells. 1 mL of the SUV-DNA solution 0.0078 Pmole 
total lipid content containing 1 Pg plasmid DNA) was added to each well, each in triplicate. After  
5 hours incubation at 37 °C in 5% CO2, the medium was replaced with growth medium (DMEM) 
containing 10% FBS and the cells were incubated for 48 hours. Transfection efficiency of each 
formulation was determined by measuring the percentage of each sample to the control. In this study 
this value is reported as luciferase activity and Lipofectin was the transfection reagent.  
2.7. Cytotoxicity Study 
Cos-7 cells were pippeted on a 96-well plate and incubated for 24 hours at 37 °C. Then 20 ȝ/ of 
MTS reagent (CellTiter 96
®
 AQueous One Solution Cell Proliferation Assay) was added to each well. 
Cells bioreduce the MTS reagent into a red formazan product. Plates were incubated for 4 hours at  
37 °C, in a 5% humid CO2 atmosphere. After that the quantity of produced formazan was measured on 
microplate reader Thermo Scientific Molecular Spectrum plate reader at A490. The absorbance reading 
is directly proportional to the number of living cells in the medium. In this study cell viability is 
calculated by comparing the results to the positive control (i.e., cells and medium) and expressed as 
a percentage.  
2.8. Langmuir Studies 
To investigate the surface pressure of monolayer lipids Langmuir-Blodgett technique has been used. 
It is an automated controlled film balance apparatus (KSV Langmuir Mini-trough, KSV Instruments 
Ltd., Helsinki, Finland) equipped with a platinum Wilhelmy plate. This instrument was used to collect 
the surface pressure-area isotherms. The trough was filled with deionised water or PBS solution as 
appropriate. The substances were prepared at fixed total concentration of 1 mg/mL of lipid in 
chloroform. 20 ȝ/ of solution was dropped on to the air/water interface with a Hamilton  
micro-syringe. The monolayer was left for 15 min to allow chloroform to evaporate. Then constant rate 
compression of 10 mm/min was performed on the monolayer molecules until collapse of the 
monolayer lipid. An external water bath circulation system maintained constant temperature of 20 °C 
for the subphase. To analyse the data KSV software (KSV Instruments Ltd., Helsinki, Finland)  
was used. 
2.9. Statistical Analysis 
Means and standard deviation were calculated for all experiments. The one-way analysis of 
variance (ANOVA) was performed on all data to determine statistical significance. The statistical 
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significance determined to 0.05 confidence intervals (P < 0.05). To compare the difference of 
significance of different conditions Tukeys post hoc test was performed.  
3. Results  
3.1. Molecular Packaging of Lipids: The Role of Lipid Structure and Electrolytes 
The Langmuir-Blodgett trough was used to investigate pure and mixed lipid monolayers for their 
interactions within the monolayer in the aqueous sub-phase of either dH2O or PBS to consider the 
translation of these studies into liposomal systems as has been previously outlined [17]. Pressure-area 
(ʌ-A) isotherms are shown in Figure 2. The extrapolated (to zero pressure) area per molecule and 
collapse pressure for the individual lipids, in either a water or PBS subphase, and also for 1:1 lipid 
mixtures are shown in Table 1. For the latter, the ideal extrapolated area per molecule was calculated 
based on taking the average area for the lipid combination, such that the calculated area could be 
compared to the actual area per molecule of the mixture. Deviations between the experimentally 
observed and the calculated ideal area may be considered as the measure of interactions between the 
mixed components since the experimentally observed area depends on the intermolecular forces 
between the lipids in the mixed monolayer. Negative deviations (where the experimental area is less 
than the ideal calculated area per molecule) indicate attractive interactions occurring between the lipids 
whilst positive deviations indicate repulsive interactions. 
Figure 2. Compression isotherm studies of the pure and mixture of lipid monolayers of 
DOPE:DOTAP, DSPE: DOTAP,DOPE:DSTAP and DSPE:DSTAP in deionised water or 
PBS at 20 °C. Results are expressed as the means of three experiments. SD has not shown 
for clarity. 
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Table 1. The experimental extrapolated area and area compressibility of mixed and pure 
monolayers at the air/aq media interface at 20 °C in dH2O or PBS as sub-phase. Results 
denote mean ± SD, n = 3. 
 
Lipid  
Extrapolated 
Area (A2/Molecule) 
Ideal Extrapolated 
Area (A2/Molecule) 
Deviation from 
Ideality (%) 
Collapse Pressure 
(mN/m) 
dH2O PBS dH2O PBS dH2O PBS dH2O PBS 
DOPE  71.9 ± 6.0 70.6 ± 7.7 - - - - 42.3 ± 0.4 42.2 ± 2.6 
DOTAP  104.3 ± 12.9 93.4 ± 10.1 - - - - 29.5 ± 1.5 42.1 ± 0.9 
DSPE  47.6 ± 0.5 45.7 ± 2.3 - - - - 55.7 ± 0.5 53.5 ± 1.0 
DSTAP  53.2 ± 2.5 53.0 ± 2.1 - - - - 50.3 ± 3.1 55.9 ± 0.8 
DOPE:DOTAP  89.7 ± 6.5 81.3 ± 5.3 88.1 82.0 +1.8 -0.9 38.4 ± 1.5 42.7 ± 0.9 
DOPE:DSTAP  81.6 ± 0.6 87.4 ± 1.6 62.6 61.8 +30.5 +41.4 38.8 ± 2.3 36.1 ± 2.4 
DSPE:DOTAP  80.6 ± 1.5 91.7 ± 1.4 75.9 69.5 +6.1 +31.9 37.7 ± 0.3 34.5 ± 0.7 
DSPE:DSTAP  46.4 ± 0.7 48.6 ± 0.2 50.4 49.3 -7.9 -1.5 52.9 ± 1.3 54.4 ± 1.2 
Considering the single component monolayers formed on dH2O, the extrapolated area per molecule 
for each of the 4 lipids was in the order of DOTAP > DOPE > DSTAP > DSPE (Table 1) with the 
cationic lipids (DOTAP and DSTAP) having a larger area per molecule than their comparable 
zwitterionic counterparts (DOPE and DSPE respectively; Table 1). The cationic lipids also formed 
liquid-expanded monolayers (Figure 2A) with lower collapse pressures than their PE counterparts 
(Table 1). Comparison between the saturated and unsaturated lipids, show that the saturated lipids are 
able to pack together closer in a solid monolayer than their unsaturated counter parts (Figure 2A) with 
DOTAP having approximately twice the measured molecular area compared to DSTAP  
(104 vs. 53 A
2
/molecule ; Table 1). Due to their closer packaging arrangement, the saturated lipids also 
display a higher collapse pressure and a more rigid monolayer than their unstaturated counterparts 
(Table 1 and Figure 2A). Formation of these monolayers on PBS rather than dH2O made no notable 
difference in the measured area per molecule; however this leaded to an increased collapse pressure in 
the case of the cationic lipid monolayers, particularly in the case of DOTAP which increased from  
29.5 to 42.1 mN/m (Table 1 and Figure 2B). This resulted in their being no significant difference in 
collapse pressures between the cationic and zwitterionic lipid monolayers when formed in PBS  
(Table 1).  
When prepared as mixed monolayers at a 1:1 molar ratio (as is commonly adopted in lipoplexes) 
the extrapolated area per molecule for the combinations was in the order of  
DOPE:DOTAP > '23('67$3 § '63('27$3 > DSPE:DSTAP with the combination of two 
unsaturated lipids gave the highest mean molecular area whilst the fully saturated mixture 
(DSPE:DSTAP) had a smaller mean molecular area of 46 A
2
 per molecule (Table 1), and formed a 
solid monolayer similar to the individual components (Figure 2). Of the 4 mixed monolayer, this 
monolayer also had the highest collapse pressure (52.9 ± 1.3 mN/m; Table 1). When the dH2O 
subphase was replaced with PBS, there was a notable increase in the extrapolated area per molecule for 
DSPE:DOTAP suggesting the presence of buffer salts was inhibiting the packaging of the monolayer 
yet the collapse pressures were not influenced by the change in subphase (Table 1).  
Considering the deviation from ideality (Table 1), which can be used to monitor molecular 
interactions between the molecules in the mixed monolayers, those lipid monolayer contains either 
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both saturated (DSPE:DSTAP) or both unsaturated (DOPE:DOTAP) lipids the deviation is minimal 
irrespective of the choice of subphase (Table 1) suggesting there was no condensing effect occurring in 
either type of monolayer. In contrast, for the monolayers combining a saturated and an unsaturated 
lipid (DOPE:DSTAP or DSPE:DOTAP) there is large positive deviations from the calculated mean 
area particularly when PBS was used as the subphase, suggesting the lipids in these mixed monolayers 
packed in a more expanded arrangement than was predicted, particularly when the systems were in 
PBS as the deviation was >30% for both DOPE:DSTAP and DSPE:DOTAP (Table 1). However these 
differences do not translate into changes in collapse pressures, with both mixed monolayers having the 
same collapse pressures in dH2O as they did in PBS (Table 1). 
Saturated long chain lipids often displace strong attractive intermolecular interactions and this is 
supported by the small molecular area and high collapse pressure of the saturated monolayer and this 
might suggest that the DSPE:DSTAP combination could give a strong low permeability liposome 
system, as has previously been shown with water soluble drugs entrapped within vesicles [2426]. 
However in the case of unsaturated lipids, these lipids are more bulky (as shown by their larger 
molecular area; Table 1) with a less densely packed arrangement that can cause a more permeable 
liposome bilayer with higher release profile of entrapped drug compared to saturated  
monolayers [17,27].  
From these results, it would suggest that the use of a fully saturated system promotes the higher 
packing density of lipids with high collapse pressure and which may promote a more rigid liposome 
system. In contrast, liposomes formed in PBS from lipid mixtures containing unsaturated lipid(s) in the 
mixture (either the helper lipid or the cationic lipid) could result in liposomes with less rigid bilayers 
(Table 1 and Figure 2). However given lipoplexes require both stability on storage and fusogenic 
properties, the consideration of how such bilayer attributes translate into liposome formulation and 
transfection attributes was considered. 
3.2. The Effect of Alkyl Chain and Electrolytes on the Characteristics of Lipoplexes 
To investigate the lipid properties on the lipoplex attributes, we attempted to formulate SUV based 
on the above combinations i.e., DOPE:DOTAP, DOPE:DSTAP, DSPE:DOTAP and DSPE:DSTAP 
SUV formulated in distilled water or PBS and mixed with plasmid DNA (gWiz
TM
 Luciferase) at a 
range of concentrations (     DQG  ȝJ). Of the four combinations, it was not 
possible to formulate DSPE:DSTAP liposomes, suggesting that whilst this combination can form a 
closely packaged solid monolayer this could not be translated into a liposomal bilayer. Similarly 
DSPE:DOTAP liposomes could only be formed in dH2O and not in PBS.  
As mentioned, saturated lipids often display strong attractive intermolecular forces which can make 
hydration and dispersion in water difficult [28,29], hence the difficulty in formulating liposomes form 
DSPE:DSTAP. The introduction of double bonds into the lipid tail (i.e., replacement of DSPE with 
DOPE or DSTAP with DOTAP) results in a less compact system which is easier to disperse in water 
[29]. The inability of DSPE:DOTAP to form vesicles in PBS might be due to the effect of salt on 
critical packaging parameter (CPP) of the lipid which is depended on length of hydrocarbon chain, 
volume of hydrophobic part and the surface area per molecule [28,29]. Dispersion of lipid molecules in 
the water may lead to different structures such as micelles, inverted micelles, hexagonal, lamellar or 
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cubic phase as well as liquid crystalline with CPP being a useful predictor of the structures formed. 
The desired CPP shape for lipids to form liposomes is a truncated cone shape (a CPP of between ½ and 
1) however studies show that liposomes can form from lipids which individually do not have the 
truncated cone shape, but when combined are able to appropriately package [2830]. In the case of 
DSPE:DOTAP, in water the molecular shape of DOTAP (with its large tail area and cationic  
head-group) may be able to compensate for the smaller DSPE molecular volume, however in the 
presence of buffer this can reduce the electrostatic nature of the DOTAP headgroup [29], therefore 
changing the shape of the molecule which means it is not able to compensate for DSPE thus 
prohibiting the formation of liposomes.  
3.2.1. Vesicle Size and Zeta Potential of Liposomes and Lipoplexes 
All five of the liposome formulations gave high DNA complexation across the DNA concentration 
range tested (Figure 3) with % DNA association being >95% in all cases showing all systems were 
able to electrostatically interact with the DNA as would be expected. However the effect this 
complexation had on the formed lipoplexes was dependent on the lipid combination and the choice of 
aqueous buffer (Figure 4). 
In all formulations, vesicle size increased with increasing DNA concentration suggesting 
aggregation of the system due to what has previously been attributed to a bridging effect [31] and/or a 
re-organisation of the system [3235] which is highly dependent on the +\í charge ratio [36]. With the 
DOPE:DOTAP formulation, the presence of the buffer salts in PBS made no significant difference in 
vesicle size, except for the highest DNA concentration tested; lipoplexes were around 300 nm if 
formulated in water compared to ~1800 nm when prepared in PBS (Figure 4). In the case of the 
DOPE:DSTAP lipoplexes, the presence of PBS was shown to significantly (p < 0.05) increase the size 
of the lipoplexes at all DNA concentrations and of the 4 formulations, DOPE:DSTAP in PBS gave the 
largest lipoplexes (Figure 4). Previous research has also shown the size of the liposomes can increase 
to double the size in the presence of PBS as the phosphate group of the PBS can perform as glue and 
increase the vesicle size by bridging the cationic polar heads of the lipid [21]. Another study reveals 
cationic liposomes have a higher tendency to aggregation when there is salt in the formulation due to 
the reduced electrostatic interactions between systems and consequently more aggregation and larger 
vesicles formed [37]. The difference in size between the formulations may be again due to the 
molecular packaging of the lipids, as more rigid assemblies, such as those formed from saturated 
cationic lipids, have been shown to preclude efficient re-organisation of this system, causing 
aggregation of large particles to form with lower transfection efficacy presumably due to reduced 
internalisation [29].  
Zeta potential studies of the systems were used to estimate the level of interaction between negative 
charges of DNA and positive charges of cationic lipid [38]. As this electrostatic interaction is one of 
the basic components of DNA complexation, and the net charge of lipoplexes is important for 
overcoming cell barriers [30,39], zeta potential studies were performed to determine the surface charge 
of the lipoplex. Results illustrate that increasing the amount of DNA over the range used had little 
effect on the cationic nature of the lipoplexes when formulated in dH2O, presumably due to the high 
cationic/anionic charge ratio (Figure 4). However in PBS, the neutralising effect of the buffer 
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electrolytes on the zeta potential can be seen, particularly for DOPE:DSTAP, where the zeta potential 
reduce from §P9LQGLVWLOOHGZDWHUIRUPXODWLRQVWR§P9DQGOHVVLQ3%6IRUPXODWLRQV 
Figure 3. DNA association within lipoplexes of DOPE:DOTAP, DOPE:DSTAP, 
DSPE:DOTAP in distilled water and PBS and in various concentrations of DNA. Results 
denote mean ± SD, n = 3. 
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Figure 4. Vesicle size (A) and Zeta potential (B) of DNA lipoplexes of DOPE:DOTAP, 
DOPE:DSTAP, DSPE:DOTAP in distilled water and PBS and in various concentrations of 
DNA. Results denote mean ± SD, n = 3. 
A       B 
 
The electrostatic interaction between positive charges of the cationic liposome and negative charges 
of phosphate groups of DNA are reported as the main interaction in formation of lipoplexes [21,31]. 
Some other researchers add that packing properties of the lipids used in the formulation of lipoplexes 
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may also play a role in condensation of the nucleic acid [40,41]. However, as it has been shown in 
Figure 4 and previously Ciani et al., [31] also demonstrated that the zeta potential of the lipoplexes are 
close to the zeta potential value of the pure liposomes at lower DNA concentrations (P > 0.05, 
ANOVA). They concluded that half of cationic molecules of the liposome are involved in the 
electrostatic interaction. These molecules are external lipids which are located on the surface of the 
liposome and when the liposome has been wrapped by DNA, the internal cationic lipids remain intact 
[31]. The effect of the buffer electrolytes in reducing the cationic charge of the lipoplexes can be due 
to the additional effect of phosphate polyanion in PBS, which reduces the positive charge of cationic 
lipids and in some cases results in their precipitation [42] however a reduction in surface charge may 
be beneficial to allow appropriate DNA dissociation from the lipoplex after cellular uptake to allow the 
DNA to reach to the nucleus [43].  
3.3. In Vitro Transfection Efficiency 
The five liposome formulations were tested for their ability to promote transfection, with 
DOPE:DSTAP in PBS showing the highest transfection levels (Figure 5). Transfection efficiency of 
lipoplexes formulated in water were in the order of DOPE:DSTAP > DSPE:DOTAP § DOPE:DOTAP, 
and DOPE:DSTAP > DOPE:DOTAP when formulated in PBS (Figure 5A). This variation in 
transfection efficacy was not related to cytotoxicity given that at the concentrations tested there was no 
significant difference between the formulations (Figure 5B). 
In general, decreasing the hydrocarbon chain length has been reported to increase transfection 
efficiency [44,45], however, given both lipids have the same carbon chain length, this case cannot be a 
reason for the variation in transfection efficiency shown in Figure 5. Equally the size, charge and 
cationic lipid/DNA ratio have all been attributed to play a role in controlling transfection [4750] 
however in the case of DSTAP and DOTAP liposomes, neither the size nor the charge of the system 
seem to correlate to its higher transfection efficacy given it is neither obviously different in size (e.g., 
DOPE:DOTAP and DOPE:DSTAP in dH2O are similar in size but have large differences in 
transfection efficacy) nor significantly different in cationic nature than the other formulations  
(Figure 4). Similarly both systems contain the fusogenic lipid DOPE which may enhance intracellular 
delivery of DNA [29]. The theory of using helper lipid comes from the original research of Flenger et 
al., in 1987 [46]. They demonstrated that the transfection activity of DOTMA when formulated with 
DOPE is more than when is formulated with DOPC and it has been proposed that the ability DOPE to 
promote the transition from lamellar phase to an inverted hexagonal phase [39] thereby promoting the 
conversion of the lamellar lipoplex phase into a non-lamellar structure due to the inverted cone-shaped 
structure of DOPE [14,44,47,48]. After endosomal uptake of the lipoplexes, the presence of DOPE in 
the formulation is suggested to aid distruption of endosomal membrane, allowing the release of the 
DNA from the endosome and the lipoplex, leaving it free it to enter the nucleus [11,31]. However in 
this study, lipoplexes formulated with DOPE:DOTAP and DSPE:DOTAP showed no significant 
difference in transfection levels suggesting that DSPE may be equally suitable as a helper lipid for 
unsaturated cationic lipids but not useful when combined with saturated lipids.  
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Figure 5. (A) Comparison of transfection efficiency of five cationic liposomes formulated 
with distilled water or PBS. Results denote mean ± SD, n = 3. (B) Relative cell viability of 
five cationic liposomes formulated with distilled water or PBS. Results denote mean ± SD, 
n = 3. 
A     B 
  
4. Conclusions  
Monolayer studies on pure lipids as well as mixture of lipids showed that saturated lipids have 
closer packaging arrangements than their unsaturated counterparts. Whilst the use of lipids that form 
condensed monolayers may be beneficial in formulating low permeability bilayers, lipid combinations 
that form highly compact monolayers are not a suitable choice for the formulation of liposomes. In 
terms of transfection efficacy, neither considering the molecular packaging of the lipoplex, nor its 
basic physicochemical attributes, have been shown to correlate with transfection efficacy with several 
general assumptions being shown to be misleading in our studies, this includes the need for the 
fusogenic lipid DOPE to promote high transfection efficacy. Similarly, the role of electrolytes in 
lipoplex formulations is shown to be dependent on the formulation, with PBS diminishing the 
transfection of DSTAP systems yet enhancing DOTAP based lipoplexes. Therefore there remains no 
clear physico-chemical screening that can be adopted to predict in vitro efficacy. Combining this with 
the lack of in vitro and in vivo efficacy that plagues non-viral delivery systems suggests that for the 
continued development of non-viral transfection agents, new tools are needed to rationalise 
these differences. 
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